Results 291 to 300 of about 683,288 (403)

Discovering the hidden emotional burden: Systematic screening for diabetes distress in adults with type 1 diabetes in nurse‐led routine diabetes care

open access: yesDiabetic Medicine, EarlyView.
Abstract Aim To gain insights into the experience of adults with type 1 diabetes (T1D) using a systematic screening method to assess and address diabetes distress (DD) in nurse‐led routine diabetes care. Methods DD screening in 30 consultations incorporated the Type 1 Diabetes Distress Scale‐7 (T1‐DDS‐7), a short‐form, validated instrument capturing ...
Vibeke Stenov   +4 more
wiley   +1 more source

Is the Prevalence of Biopsy-Proven Glomerulopathies in Adults Changing Over Time? [PDF]

open access: yesMaedica (Bucur)
Pana N   +5 more
europepmc   +1 more source

Early onset of diabetic nephropathy [PDF]

open access: bronze, 1997
Jane M Francis   +3 more
openalex   +1 more source

Unravelling the heterogeneity of diabetes in chronic pancreatitis: Alpha and beta cell dysfunction and association with glycaemic control

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Diabetes in patients with chronic pancreatitis is a heterogeneous condition with some patients presenting with pre‐existing diabetes and others developing diabetes after pancreatitis onset. We aimed to characterise beta and alpha cell function in these patients and examine differences between those with and without pre‐existing diabetes ...
Line Davidsen   +12 more
wiley   +1 more source

The Impact of Patient Age on Causes of Graft Loss After Renal Transplantation. [PDF]

open access: yesTranspl Int
Winkler S   +9 more
europepmc   +1 more source

Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2473-2484, May 2025.
Abstract Aims Anti‐vascular endothelial growth factor (VEGF) therapy is the standard treatment for diabetic macular oedema (DMO); however, unmet needs remain. This study aimed to assess the effectiveness of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in treating DMO.
Ryoichi Ishibashi   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy